Lv1
30 积分 2024-07-18 加入
1166P A phase I study of JS207, a PD-1/VEGF bispecific antibody, in patients with advanced malignancies
7个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
11个月前
已完结
VEGF-A drives TOX-dependent T cell exhaustion in anti–PD-1–resistant microsatellite stable colorectal cancers
1年前
已完结
Interleukin 10 Antioxidant Effect Decreases Leukocytes/Endothelial Interaction Induced by Tumor Necrosis Factor α
1年前
已完结
皖公网安备34019202002308
